Overall impact
B (79)

Commentary

Advanzeon is a strong overall performer. With a 'B' rating of 79.1 for overall impact (93rd percentile compared to all companies), Advanzeon ranks 2nd out of 17 industry peers, behind Corestream, and ahead of Corestream, Cigna, Elevance Health and 12 others. On top material causes for Advanzeon's industry (Health Insurance), Advanzeon performs well in Improved Mental Health (84.8 score), Reduced Use of tobacco (91.6), Child and Maternal Health (95.0) and 5 other causes where it received an 'A' score and performs poorly in Reduced Green House Gas Emissions (26.3 score).
Impact
Cause CHCR
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Advanzeon

Employees
2
Sector
Financials
Industry
Insurance
Sub-industry
Life & Health Insurance
SASB industry
Insurance
Headquarters
Fl, United States
Share classes
CHCR
Description
Advanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 8, 2022, the voluntary petition of Advanzeon Solutions, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2020.
Material causes
Ethos considers the following causes material for Advanzeon, based on its industry sub-industry Life & Health Insurance. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.